共 50 条
- [31] SPIRIT II clinical study:: A clinical evaluation of the XIENCE™ v Everolimus Eluting Coronary Stent System in the treatment of patients with de novo native coronary artery lesions AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (8A): : 147M - 147M
- [32] Everolimus-eluting stents in patients undergoing percutaneous coronary intervention: Final 3-year results of the Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Subjects With de Novo Native Coronary Artery Lesions trial AMERICAN HEART JOURNAL, 2013, 166 (06) : 1035 - 1042
- [36] Efficacy of everolimus-eluting stent implantation in patients with small coronary arteries (≤2.5 mm): outcomes of 3-year clinical follow-up Heart and Vessels, 2017, 32 : 796 - 803
- [37] Comparison of Everolimus-Eluting and Paclitaxel-Eluting Coronary Stents in Patients Undergoing Multilesion and Multivessel Intervention The SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System [EECSS] in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) and SPIRIT IV (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) Randomized Trials JACC-CARDIOVASCULAR INTERVENTIONS, 2010, 3 (12) : 1229 - 1239
- [38] An Upfront Two-Stent Strategy for True Coronary Bifurcation Lesions with A Large Side Branch in Acute Coronary Syndrome: A Two-Year Follow-Up Study MEDICINA-LITHUANIA, 2020, 56 (03):